Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2021/036638external-prioritypatent/WO2021252644A1/en
Application filed by Pardes Biosciences IncfiledCriticalPardes Biosciences Inc
Publication of CO2022017895A2publicationCriticalpatent/CO2022017895A2/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se proveen compuestos de la Fórmula II con cargas activas (“warheads”) y su uso para el tratamiento de enfermedades y trastornos clínicos tales como las infecciones virales; también se proveen composiciones farmacéuticas y métodos para preparar distintos compuestos con carga activa; se observa que los compuestos inhiben proteasas tales como la proteasa tipo 3C, CL- o 3CL.Compounds of Formula II with active charges ("warheads") and their use for the treatment of diseases and clinical disorders such as viral infections are provided; Pharmaceutical compositions and methods for preparing various compounds with active charge are also provided; The compounds are shown to inhibit proteases such as type 3C, CL- or 3CL protease.
CONC2022/0017895A2020-06-092022-12-09
Cysteine protease inhibitors and their methods of use
CO2022017895A2
(en)